Document Detail


Type 1 diabetes: primary antigen/peptide/register/trimolecular complex.
MedLine Citation:
PMID:  22956469     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Type 1A diabetes (autoimmune) is now immunologically predictable in man, but preventable only in animal models. What triggers the development of autoimmunity in genetically susceptible individuals remains unknown. Studies of non-obese diabetic (NOD) mice reveal that interactions between T-cell receptors of diabetogenic T cell and an MHC class II loaded with an autoantigen are key determinates of the disease. With insulin as the primary target in the NOD mouse, likely man, and possibly the RT1-U rat models, therapeutic targeting of the components of these anti-insulin trimolecular complexes we believe provide a fulcrum for development of preventive therapy. In particular for the NOD mouse model, there is extensive evidence that the dominant insulin peptide driving disease initiation is insulin B chain amino acids 9-23 (SHLVEALYLVCGERG) recognized predominantly by germ-line sequences of a specific T-cell receptor Valpha (TRAV5D-4), and small molecules or monoclonal antibodies directed at this recognition complex can prevent diabetes.
Authors:
Tomasz Sosinowski; George S Eisenbarth
Related Documents :
24792749 - In-depth metabolic phenotyping of genetically engineered mouse models in obesity and di...
24498189 - Brown norway chromosome 1 congenic reduces symptoms of renal disease in fatty zucker rats.
24269779 - Attenuation of diabetic nephropathy by chaihuang-yishen granule through anti-inflammato...
24533859 - Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hypergly...
23586429 - Rapidly evolving hypopituitarism in a boy with multiple autoimmune disorders.
20946939 - Chronic ethanol ingestion, type 2 diabetes mellitus, and brain-derived neurotrophic fac...
22711049 - Short-term multimodal phototherapy approach in a diabetic ulcer patient.
3075899 - Macrovascular disease and hyperinsulinaemia.
3057889 - Diabetic microangiopathy, genetics, environment, and treatment.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Immunologic research     Volume:  55     ISSN:  1559-0755     ISO Abbreviation:  Immunol. Res.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-01-11     Completed Date:  2013-06-13     Revised Date:  2014-03-19    
Medline Journal Info:
Nlm Unique ID:  8611087     Medline TA:  Immunol Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  270-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Autoantigens / immunology
Diabetes Mellitus, Type 1 / immunology*
Genes, MHC Class II
Humans
Peptides / immunology
Receptors, Antigen, T-Cell / immunology
Grant Support
ID/Acronym/Agency:
N01 AI 15416/AI/NIAID NIH HHS; P30 DK057516/DK/NIDDK NIH HHS; R01 DK 032083/DK/NIDDK NIH HHS; R01 DK032083/DK/NIDDK NIH HHS; U19AI050864/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Autoantigens; 0/Peptides; 0/Receptors, Antigen, T-Cell
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Peripheral tolerance and autoimmunity: lessons from in vivo imaging.
Next Document:  Ribosomal DNA distribution and a genus-wide phylogeny reveal patterns of chromosomal evolution in Al...